AR043773A1 - FORMULATIONS AND ITS USE - Google Patents

FORMULATIONS AND ITS USE

Info

Publication number
AR043773A1
AR043773A1 ARP040100982A ARP040100982A AR043773A1 AR 043773 A1 AR043773 A1 AR 043773A1 AR P040100982 A ARP040100982 A AR P040100982A AR P040100982 A ARP040100982 A AR P040100982A AR 043773 A1 AR043773 A1 AR 043773A1
Authority
AR
Argentina
Prior art keywords
agents
subject
overactive bladder
another
tolterodine
Prior art date
Application number
ARP040100982A
Other languages
Spanish (es)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of AR043773A1 publication Critical patent/AR043773A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Reivindicación 1: Una formulación farmacéutica administrada por vía oral caracterizada porque comprende tolterodina, que opcionalmente comprende sus sales, complejos, profármacos y metabolitos, que comprende cacao en polvo. Reivindicación 20: Una formulación de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque comprende además otro u otros agentes que tienen un efecto contra vejiga hiperactiva. Reivindicación 21: Una formulación de acuerdo con la reivindicación 20, caracterizada porque él, otro u otros, agentes se elige(n) de oxobutinina, emepromio, trospio, propanetelina y darifenacina. Reivindicación 24: Procedimiento para tratar vejiga hiperactiva en un sujeto caracterizado porque comprende la administración al sujeto de una formulación farmacéutica administrativa por vía oral que contiene tolterodina de acuerdo con una cualquiera de las reivindicaciones 1-22.Claim 1: An orally administered pharmaceutical formulation characterized in that it comprises tolterodine, which optionally comprises its salts, complexes, prodrugs and metabolites, which comprises cocoa powder. Claim 20: A formulation according to any of the preceding claims, characterized in that it further comprises another or other agents that have an effect against overactive bladder. Claim 21: A formulation according to claim 20, characterized in that he, another or other agents are chosen from oxobutinin, emepromium, trospium, propanetelin and darifenacin. Claim 24: Method for treating overactive bladder in a subject characterized in that it comprises administering to the subject an oral pharmaceutical formulation containing tolterodine according to any one of claims 1-22.

ARP040100982A 2003-03-26 2004-03-24 FORMULATIONS AND ITS USE AR043773A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300830A SE0300830D0 (en) 2003-03-26 2003-03-26 New formulations and use thereof

Publications (1)

Publication Number Publication Date
AR043773A1 true AR043773A1 (en) 2005-08-10

Family

ID=20290785

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100982A AR043773A1 (en) 2003-03-26 2004-03-24 FORMULATIONS AND ITS USE

Country Status (12)

Country Link
EP (1) EP1605920A1 (en)
JP (1) JP2006521347A (en)
CN (1) CN1764441A (en)
AR (1) AR043773A1 (en)
AU (1) AU2004224556A1 (en)
BR (1) BRPI0408743A (en)
CA (1) CA2519119A1 (en)
CL (1) CL2004000625A1 (en)
MX (1) MXPA05010314A (en)
SE (1) SE0300830D0 (en)
WO (1) WO2004084864A1 (en)
ZA (1) ZA200506710B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1907136B (en) * 2006-07-28 2010-08-25 张新生 Vegetation health care milk-like liquid and preparation method thereof
KR101660666B1 (en) 2007-06-13 2016-09-27 오츠카 세이야쿠 가부시키가이샤 Equol-containing food
JP5702926B2 (en) 2009-10-16 2015-04-15 東レ・ダウコーニング株式会社 Treatment composition for wiping paper

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB918955A (en) * 1960-05-19 1963-02-20 Thomae Gmbh Dr K Pharmaceutical laxative compositions comprising 4,4-dihydroxy-2-amino triphenylmethane
SE9803986D0 (en) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
JP2001114668A (en) * 1999-10-13 2001-04-24 Meiji Seika Kaisha Ltd Chocolate preparation
DE60021749T2 (en) * 1999-11-11 2006-04-20 Pfizer Health Ab PHARMACEUTICAL FORMULATION CONTAINING TOLTERODINE AND ITS USE

Also Published As

Publication number Publication date
CN1764441A (en) 2006-04-26
JP2006521347A (en) 2006-09-21
SE0300830D0 (en) 2003-03-26
CA2519119A1 (en) 2004-10-07
AU2004224556A1 (en) 2004-10-07
WO2004084864A1 (en) 2004-10-07
CL2004000625A1 (en) 2005-01-07
BRPI0408743A (en) 2006-03-28
ZA200506710B (en) 2006-11-29
MXPA05010314A (en) 2006-05-19
EP1605920A1 (en) 2005-12-21

Similar Documents

Publication Publication Date Title
ES2498095T3 (en) Pharmaceutical composition comprising fentanyl for the treatment of cancer or intercurrent or acute pain by sublingual administration
PA8559501A1 (en) PHARMACEUTICAL FORMULATIONS OF 5,7,14-TRIAZATETRACICLO [10.3.1.02,11.04,9] -HEXADECA-2 (11), 3,5,7,9-PENTAENO
CL2004000564A1 (en) PHARMACEUTICAL FORMULATION FOR ORAL ADMINISTRATION THAT INCLUDES ONE OR MORE PHARMACEUTICALLY ACTIVE AGENTS AND COCOA POWDER.
CR7362A (en) PHARMACEUTICAL FORMULATIONS OF PLATINUM DERIVATIVE
CO5150154A1 (en) SUBSTRATE COMPOSITION AND METHOD FOR USE FOR THE SEQUESTRAY OF SKIN IRRITANTS
CL2004000931A1 (en) CONSUMABLE FILM ADAPTED TO ADHER AND DISSOLVE IN THE ORAL CAVITY THAT INCLUDES A MODIFIED ALMIDON AND A PHARMACEUTICALLY ACTIVE AGENT.
MX2009001711A (en) Sustained-release formulations of topiramate.
AR053002A1 (en) ORAL COMPOSITIONS CONTAINING OXIDIZED CAMELLIA
RS51764B (en) Transdermal pharmaceutical composition
NO20003472D0 (en) TTS containing an antioxidant
DK1294353T3 (en) Use of an (R) -enantiomer of lipoic acid in cosmetic and dermatological compositions
AR045572A1 (en) A COMBINATION THAT INCLUDES N- (3-METOXI-5-METHYLPIRAZIN-2-IL) -2- (4- [1,3,4-OXADIAZOL-2-IL] PHENYL-3-SULFONAMIDE AND AN ANALOG LHRH AND / OR A bisphosphonate
ECSP045029A (en) VALDECOXIB COMPOSITIONS OF INTRAORAL DISGREGATION
AR034813A1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
HUP0100539A2 (en) Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
DK1345595T3 (en) Ion strength-independent pharmaceutical formulation with depot release
HUP0203197A2 (en) Use of docetaxel for treating hepatocellular carcinoma
AR043773A1 (en) FORMULATIONS AND ITS USE
AR039895A1 (en) COMPOSITION THAT INCLUDES A VITAMIN, A METAL SALT AND AN INSULIN OR A HORMONE OF THE GROWTH AND USE OF SUCH COMPONENTS TO PREPARE IT
BRPI0514258A (en) compositions and systems for use in the oral cavity
DK1091733T3 (en) (-) - Pseudoephedrine as a sympathomimetic drug
ES2187030T3 (en) A NEW SALT
AR040515A1 (en) TOPICA PHARMACEUTICAL FORMULA STABILIZED WITH KETOPROPHENE CONTENT
AR043412A1 (en) PHARMACEUTICAL FORMULATIONS THAT INCLUDE A MASTERING AGENT OF AMARGO FLAVOR

Legal Events

Date Code Title Description
FA Abandonment or withdrawal